Phibro Animal Health ( (PAHC) ) is experiencing volatility. Read on for a possible explanation for the stock’s unusual movement.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Phibro Animal Health shares are sliding as investors react to fresh concerns that the stock has become significantly overvalued, prompting profit-taking after its recent 52-week high. Sentiment soured further after reports of large insider sales by CEO Jack Bendheim and other executives, which many traders view as a bearish signal near peak prices.
Analysts now argue that the stock could still have sizable downside from current levels, warning of a potential drop of roughly 15 percent to 32 percent before it reaches their estimates of fair value. Those valuation calls are adding pressure to the share price, reinforcing the selloff as short-term traders rush to lock in earlier gains.
More about Phibro Animal Health
YTD Price Performance: 52.96%
Average Trading Volume: 272,531
Technical Sentiment Signal: Buy
Current Market Cap: $2.31B
For further insights into PAHC stock on TipRanks’ Stock Analysis page.
See more of today’s top stock gainers and losers.